✦ LIBER ✦

Pentoxifylline efficacy in the treatment of intermittent claudication: Multicenter controlled double-blind trial with objective assessment of chronic occlusive arterial disease patients

✍ Scribed by John M Porter; Bruce S Cutler; Bok Y Lee; Theobald Reich; Frederick A Reichle; John T Scogin; D.Eugene Strandness

Book ID: 115656568
Publisher: Elsevier Science
Year: 1982
Tongue: English
Weight: 773 KB
Volume: 104
Category: Article
ISSN: 1097-6744
DOI: 10.1016/0002-8703(82)90642-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A randomised, double blind, placebo-cont

A randomised, double blind, placebo-controlled study to determine the efficacy of immune modulation therapy in the treatment of patients suffering from peripheral arterial occlusive disease with intermittent claudication

✍ C. McGrath; R. Robb; A.J. Lucas; A.H.R. Stewart; C.L. Underwood; J.K. Horridge; 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 260 KB

A Randomised, Double Blind, Placebo-cont

A Randomised, Double Blind, Placebo-controlled Study to Determine the Efficacy of Immune Modulation Therapy in the Treatment of Patients Suffering from Peripheral Arterial Occlusive Disease with Intermittent Claudication

✍ C. McGrath; R. Robb; A.J. Lucas; A.H.R. Stewart; C.L. Underwood; J.K. Horridge; 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 151 KB

Efficacy of perindopil in reduction of c

Efficacy of perindopil in reduction of cardiovascular events among patients with stable coronary artery disease: randomized, double-blind, placebo-controlled, multicenter trial (the EUROPA study)

📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 39 KB

Efficacy and safety of high-dose pravast

Efficacy and safety of high-dose pravastatin in hypercholesterolemic patients with well-compensated chronic liver disease: Results of a prospective, randomized, double-blind, placebo-controlled, multicenter trial

✍ James H. Lewis; Mary Ellen Mortensen; Steven Zweig; Mary Jean Fusco; Jeffrey R. 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 148 KB 👁 2 views

The hepatotoxic potential of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors in patients with underlying chronic liver disease remains controversial. We performed a multicenter, randomized, double-blind, placebo-controlled, parallel-group trial that compared pravastatin (80 mg) to a place

Efficacy and safety of rebamipide for th

Efficacy and safety of rebamipide for the treatment of dry mouth symptoms in patients with Sjögren’s syndrome: a double-blind placebo-controlled multicenter trial

✍ Susumu Sugai; Hiroki Takahashi; Shuji Ohta; Makoto Nishinarita; Masami Takei; Sh 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 413 KB

Multicenter, Double-Blind, Randomized, P

Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial Assessing the Efficacy and Safety of Proton Pump Inhibitor Lansoprazole in Infants with Symptoms of Gastroesophageal Reflux Disease

✍ Susan R. Orenstein; Eric Hassall; Wanda Furmaga-Jablonska; Stuart Atkinson; Mars 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 517 KB